Biography of Noubar Afeyan | |
|
Noubar B. Afeyan, Ph.D. has served as a member of our board of directors since 2013. Previously, Dr. Afeyan served as our President from April 2013 to May 2014 and as the Chairman of our board of directors from April 2013 to December 2014 and from July 2016 to January 2017. In 1999, Dr. Afeyan founded Flagship Pioneering and serves as its Senior Managing Partner and Chief Executive Officer. Since August 2010, Dr. Afeyan has served on the board of directors of Moderna, Inc. He currently serves on the boards of numerous privately held companies, and has previously served on the boards of numerous privately and publicly held companies, including Seres Therapeutics, Inc., Evelo Biosciences, Inc., Kaleido Biosciences, Inc. and BG Medicine, Inc. He received a Ph.D. in biochemical engineering from the Massachusetts Institute of Technology and a B.S. in chemical engineering from McGill University. Dr. Afeyan is currently a visiting lecturer of business administration at Harvard Business School. We believe that Dr. Afeyan’s significant experience co-founding, leading and investing in numerous biotechnology companies make him qualified to serve on our board of directors.
|
Current positions of Noubar Afeyan | |
|
Name | Title |
Since |
Moderna, Inc. (Biotechnology & Medical Research) |
Chairman |
2012 | Omega Therapeutics, Inc. (Biotechnology & Medical Research) |
Chairman |
2016 | Rubius Therapeutics, Inc. (Biotechnology & Medical Research) |
Independent Director |
2013 | Flagship Pioneering |
Founder & CEO |
- | Alltrna |
Chairman |
- | Laronde Inc. |
Chairman |
- | Generate Biomedicines, Inc. |
Chairman |
- | Tessera Therapeutics, Inc. |
Chairman |
- | ModernaTX, Inc. |
Chairman |
2013 | LS Dissolution, Inc. |
Director |
2005 | YourBio Health, Inc. |
Director |
- | Massachusetts Institute of Technology |
Trustee |
2016 | Inzen Therapeutics, Inc. |
Director |
- | Boston Symphony Orchestra, Inc. |
Director |
2008 | Cellarity Inc. |
Director |
2017 | Ring Therapeutics, Inc. |
Director |
- | Cobalt Biomedicine, Inc. |
Director |
- | Cogen Immune Medicine, Inc. |
Director |
- | Armenian General Benevolent Union |
Director |
- | Epiva Biosciences, Inc. |
Director |
- | Ameriabank CJSC |
Director |
2010 | IDEA Foundation |
Director |
2016 | Dilijan International School of Armenia |
Director |
- | Armenia 2020 |
Director |
- | Flagship Ventures Fund IV-RX LP |
Manager |
- | Flagship Ventures Fund IV LP |
Manager |
- |
|
Holdings of Noubar Afeyan | |
|
Name | Equities | % | Valuation |
Moderna, Inc. (MRNA) (Biotechnology & Medical Research) | 2,239,673 | 0.56% | 301,034,448 USD |
Rubius Therapeutics, Inc. (RUBY) (Biotechnology & Medical Research) | 0 | 0.0000% | 0 USD |
|
Noubar Afeyan : Personal Network | |
|
Name | Linked companies |
Robert Langer | Moderna, Inc. Rubius Therapeutics, Inc. YourBio Health, Inc. Massachusetts Institute of Technology ModernaTX, Inc. |
John D. Mendlein | Moderna, Inc. Omega Therapeutics, Inc. Laronde Inc. Tessera Therapeutics, Inc. ModernaTX, Inc. Flagship Pioneering |
David A. Berry | Omega Therapeutics, Inc. Cogen Immune Medicine, Inc. LS Dissolution, Inc. Epiva Biosciences, Inc. Flagship Pioneering |
Stéphane Bancel | Moderna, Inc. Generate Biomedicines, Inc. ModernaTX, Inc. Flagship Pioneering |
Stephen A. Berenson | Moderna, Inc. Cellarity Inc. ModernaTX, Inc. Flagship Pioneering |
Marcello Damiani | Moderna, Inc. Cellarity Inc. ModernaTX, Inc. |
David R. Epstein | Rubius Therapeutics, Inc. Ring Therapeutics, Inc. Flagship Pioneering |
Michael A. Rosenblatt | Rubius Therapeutics, Inc. Cobalt Biomedicine, Inc. Flagship Pioneering |
Paula Hammond | Moderna, Inc. Massachusetts Institute of Technology |
Elizabeth G. Nabel | Moderna, Inc. ModernaTX, Inc. |
|
© 2022 People and Ownership :
|
Noubar Afeyan : Connections | |
|
|
Latest news about Noubar Afeyan | |
|
|
|